The Goldman Sachs Group Boosts Core & Main (NYSE:CNM) Price Target to $38.00
Core & Main (NYSE:CNM – Free Report) had its price objective increased by The Goldman Sachs Group from $34.00 to $38.00 in a report issued...
Avantor (NYSE:AVTR) Given New $26.00 Price Target at The Goldman Sachs Group
Avantor (NYSE:AVTR – Free Report) had its price objective boosted by The Goldman Sachs Group from $23.00 to $26.00 in a research note released on...
Neurocrine Biosciences’ (NBIX) “Buy” Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reissued their buy rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report published on Thursday, Benzinga reports. Canaccord...
KORU Medical Systems (NASDAQ:KRMD) Stock Rating Reaffirmed by Canaccord Genuity Group
Canaccord Genuity Group reiterated their buy rating on shares of KORU Medical Systems (NASDAQ:KRMD – Free Report) in a research note published on Thursday, Benzinga...
R1 RCM (NASDAQ:RCM) Receives Buy Rating from Canaccord Genuity Group
Canaccord Genuity Group restated their buy rating on shares of R1 RCM (NASDAQ:RCM – Free Report) in a report issued on Thursday morning, Benzinga reports....
Exxon Mobil’s (XOM) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Royal Bank of Canada reissued their sector perform rating on shares of Exxon Mobil (NYSE:XOM – Free Report) in a report published on Thursday, Benzinga...